StreetAlpha
Solid Biosciences Inc. · SEC Form 4

SLDB Insider Trading

From SEC Form 447 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Solid Biosciences Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.7M sold.

← SLDB stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$2.7M27 sales · 7 insiders
Net−$2.7Mbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $117KDec2026-01: sold $37KJan2026-02: sold $2.5MFebMarAprMayJunJulAugSep2026-10: sold $25KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when SLDB insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an SLDB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every SLDB insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 19, 2026Gabriel BrooksChief Medical OfficerSale plan4,374$5.62$25K97,241Oct 20Form 4
Feb 18, 2026Kevin TanCFO & TreasurerSale plan5,404$5.82$31K99,422Feb 18Form 4
Feb 18, 2026David T HowtonCOOSale plan7,469$5.82$43K105,077Feb 18Form 4
Feb 18, 2026Paul HerzichChief Technology OfficerSale plan3,616$5.82$21K72,638Feb 18Form 4
Feb 18, 2026Ilan GanotDirectorSale plan2,658$5.82$15K27,474Feb 18Form 4
Feb 18, 2026Jessie HanrahanChief Regulatory OfficerSale plan4,134$5.82$24K74,318Feb 18Form 4
Feb 18, 2026Alexander CumboPresident and CEOSale plan16,644$5.82$97K235,405Feb 18Form 4
Feb 4, 2026Paul HerzichChief Technology OfficerSale plan10,905$6.44$70K69,067Feb 6Form 4
Feb 4, 2026Jessie HanrahanChief Regulatory OfficerSale plan12,348$6.44$80K70,327Feb 6Form 4
Feb 4, 2026Gabriel BrooksChief Medical OfficerSale plan12,616$6.44$81K84,092Feb 6Form 4
Feb 4, 2026Kevin TanCFO & TreasurerSale plan14,783$6.44$95K94,201Feb 6Form 4
Feb 4, 2026Ilan GanotDirectorSale plan7,205$6.44$46K25,271Feb 6Form 4
Feb 4, 2026Alexander CumboPresident and CEOSale plan48,913$6.44$315K222,018Feb 6Form 4
Feb 4, 2026David T HowtonCOOSale plan18,894$6.44$122K97,859Feb 6Form 4
Feb 2, 2026Paul HerzichChief Technology OfficerSale plan26,250$6.44$169K79,972Feb 2Form 4
🔒 32 more trades. Create a free account or sign in to see them all.

SLDB insider trading FAQ

Are SLDB insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of SLDB on the open market in 0 trades, and 7 sold $2.7M in 27 trades, 100% of that under pre-arranged trading plans.

When did an SLDB insider last buy shares?

Clare Kahn (Director) bought 1,860 shares for $10K on Mar 11, 2025, reported on Mar 13, 2025.

When did an SLDB insider last sell shares?

Gabriel Brooks (Chief Medical Officer) sold 4,374 shares for $25K on Oct 19, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice